Montana complaint against Lilly alleges off-label Zyprexa marketing
Pharma Compliance Alert, March 21, 2007
Last week, Montana became the seventh state to sue Eli Lilly over its alleged off-label marketing of the antipsychotic drug Zyprexa. In addition, the state's Attorney General Mike McGrath also alleges that Lilly gave kickbacks to doctors, reports Bloomberg News.
According to the report, Montana's complaint also accuses Lilly of "instructing its representatives to minimize and misrepresent the dangers of Zyprexa." The state is seeking all funds that Montana or its citizens spent on Zyprexa since the drug was launched in 1996, treble damages, and attorneys' fees.
The Montana complaint is only the latest in a string of accusations against Lilly regarding Zyprexa. Earlier this month, the Commonwealth of Pennsylvania sued Lilly alleging deceptive marketing, and Representative Henry Waxman (D-CA), chair of the Committee on Oversight and Government Reform, requested information about Lilly's Zyprexa marketing.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched